The right infusion depends on your history, labs, and goals which is exactly why every IV protocol at LiveNow Longevity is physician-designed and supervised by Dr
RenewMD Fremont: (510) 744-1582 RenewMD Folsom/Sacramento: (916) 245-3043 RenewMD Stockton: (209) 952-2251 See all RenewMD Monthly Specials HERE Specials
View the research paper.

After opening commercial serum Once opened (seal broken): Air exposure begins Bacterial contamination possible Oxidation accelerates Shorter shelf life Track opening date Shelf life after opening: Why packaging matters: Airless pump: Minimal air contact, longest life Dropper: Some air exposure, moderate life Jar: Maximum air exposure, shortest life Finger contamination risk (jar) Best practices after opening: Refrigerate after opening (extends life) Close tightly after each use Don't contaminate (no fingers in product) Use within 6 months ideally Note opening date on bottle Signs commercial serum degraded: Color change (darkening, blue-green tint) Smell change (rancid or off odor) Texture change (separation, clumping) Reduced efficacy (no longer works) Irritation (preservatives depleted, bacteria) When to discard: Past expiration date + 3-6 months opened Any signs of degradation above Unusual smell or color Product separated and won't remix Skin irritation develops Commercial vs DIY serum stability Commercial serum advantages: Professional preservative systems pH buffered correctly Antioxidants included Tested stability (12-24 months unopened) Quality assurance DIY serum challenges: No professional preservatives (or inadequate) pH optimization difficult Limited antioxidant protection Short shelf life (1-2 weeks refrigerated) Bacterial contamination risk Comparison: When DIY acceptable: Make small batches (1-2 weeks supply) Use immediately Refrigerate always Accept short shelf life Understand contamination risk When commercial better: Want convenience Need longer shelf life Travel frequently Don't want frequent preparation Value safety/stability See DIY GHK-Cu serum recipe for home formulation

Although CMS sent a memo to state Medicaid directors about this designation in 2016 (CMS, 2016e) and updated Chapter 16B of the Medicare Managed Care Manual (CMS, 2016b) to include more description of the category, few of the states or plans with which we spoke during our case studies or at our in-person meeting reported that they understood how these plans worked or why it might be beneficial for them to pursue this designation